Hybridoma

To date, we have worked with more than 50 biotech and pharmaceutical companies and research institutes worldwide and deliver antibodies meeting the desired specifications successfully for their assays and product development. We are continuously improving our service platforms and expanding our capabilities in the demanding areas such as GPCR/ion-channel antibody and ADC antibody discovery.
- Service Overview
- Discovery Chemistry
- Biology & Pharmacology
- DMPK / Exploratory Toxicology
- Biologics Discovery
- Biologics CMC
- Small Molecule CMC